Exposure to endocrine-disrupting chemicals in the USA: a population-based disease burden and cost analysis
- PMID: 27765541
- DOI: 10.1016/S2213-8587(16)30275-3
Exposure to endocrine-disrupting chemicals in the USA: a population-based disease burden and cost analysis
Abstract
Background: Endocrine-disrupting chemicals (EDCs) contribute to disease and dysfunction and incur high associated costs (>1% of the gross domestic product [GDP] in the European Union). Exposure to EDCs varies widely between the USA and Europe because of differences in regulations and, therefore, we aimed to quantify disease burdens and related economic costs to allow comparison.
Methods: We used existing models for assessing epidemiological and toxicological studies to reach consensus on probabilities of causation for 15 exposure-response relations between substances and disorders. We used Monte Carlo methods to produce realistic probability ranges for costs across the exposure-response relation, taking into account uncertainties. Estimates were made based on population and costs in the USA in 2010. Costs for the European Union were converted to US$ (€1=$1·33).
Findings: The disease costs of EDCs were much higher in the USA than in Europe ($340 billion [2·33% of GDP] vs $217 billion [1·28%]). The difference was driven mainly by intelligence quotient (IQ) points loss and intellectual disability due to polybrominated diphenyl ethers (11 million IQ points lost and 43 000 cases costing $266 billion in the USA vs 873 000 IQ points lost and 3290 cases costing $12·6 billion in the European Union). Accounting for probability of causation, in the European Union, organophosphate pesticides were the largest contributor to costs associated with EDC exposure ($121 billion), whereas in the USA costs due to pesticides were much lower ($42 billion).
Interpretation: EDC exposure in the USA contributes to disease and dysfunction, with annual costs taking up more than 2% of the GDP. Differences from the European Union suggest the need for improved screening for chemical disruption to endocrine systems and proactive prevention.
Funding: Endocrine Society, Ralph S French Charitable Foundation, and Broad Reach Foundation.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Comment in
-
The economic legacy of endocrine-disrupting chemicals.Lancet Diabetes Endocrinol. 2016 Dec;4(12):961-962. doi: 10.1016/S2213-8587(16)30279-0. Epub 2016 Oct 17. Lancet Diabetes Endocrinol. 2016. PMID: 27765540 No abstract available.
-
Stand firm on hormone disruptors.Nature. 2016 Nov 24;539(7630):469. doi: 10.1038/539469a. Nature. 2016. PMID: 27882994 No abstract available.
-
Endocrine disruptors: The burden of endocrine-disrupting chemicals in the USA.Nat Rev Endocrinol. 2016 Dec 8;13(1):6-7. doi: 10.1038/nrendo.2016.198. Nat Rev Endocrinol. 2016. PMID: 27929035 No abstract available.
Similar articles
-
Neurobehavioral deficits, diseases, and associated costs of exposure to endocrine-disrupting chemicals in the European Union.J Clin Endocrinol Metab. 2015 Apr;100(4):1256-66. doi: 10.1210/jc.2014-4323. Epub 2015 Mar 5. J Clin Endocrinol Metab. 2015. PMID: 25742515 Free PMC article.
-
Estimating burden and disease costs of exposure to endocrine-disrupting chemicals in the European union.J Clin Endocrinol Metab. 2015 Apr;100(4):1245-55. doi: 10.1210/jc.2014-4324. Epub 2015 Mar 5. J Clin Endocrinol Metab. 2015. PMID: 25742516 Free PMC article.
-
Burden of disease and costs of exposure to endocrine disrupting chemicals in the European Union: an updated analysis.Andrology. 2016 Jul;4(4):565-72. doi: 10.1111/andr.12178. Epub 2016 Mar 22. Andrology. 2016. PMID: 27003928 Free PMC article.
-
Human cost burden of exposure to endocrine disrupting chemicals. A critical review.Arch Toxicol. 2017 Aug;91(8):2745-2762. doi: 10.1007/s00204-017-1985-y. Epub 2017 May 20. Arch Toxicol. 2017. PMID: 28528477 Review.
-
Endocrine-disrupting chemicals: economic, regulatory, and policy implications.Lancet Diabetes Endocrinol. 2020 Aug;8(8):719-730. doi: 10.1016/S2213-8587(20)30128-5. Lancet Diabetes Endocrinol. 2020. PMID: 32707119 Free PMC article. Review.
Cited by
-
Reproductive toxicology of environmental endocrine-disrupting chemicals in women: a cohort study protocol.Front Cell Dev Biol. 2024 Jun 3;12:1335028. doi: 10.3389/fcell.2024.1335028. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 38887521 Free PMC article.
-
Empowering Student Pharmacists to Counsel Patients on Endocrine Disrupting Chemicals through Interactive Role-Play.Pharmacy (Basel). 2024 Mar 26;12(2):55. doi: 10.3390/pharmacy12020055. Pharmacy (Basel). 2024. PMID: 38668081 Free PMC article.
-
The Conflict between Regulatory Agencies over the 20,000-Fold Lowering of the Tolerable Daily Intake (TDI) for Bisphenol A (BPA) by the European Food Safety Authority (EFSA).Environ Health Perspect. 2024 Apr;132(4):45001. doi: 10.1289/EHP13812. Epub 2024 Apr 9. Environ Health Perspect. 2024. PMID: 38592230 Free PMC article.
-
Public Health Risks of PFAS-Related Immunotoxicity Are Real.Curr Environ Health Rep. 2024 Jun;11(2):118-127. doi: 10.1007/s40572-024-00441-y. Epub 2024 Mar 25. Curr Environ Health Rep. 2024. PMID: 38526771 Free PMC article. Review.
-
Transformers enable accurate prediction of acute and chronic chemical toxicity in aquatic organisms.Sci Adv. 2024 Mar 8;10(10):eadk6669. doi: 10.1126/sciadv.adk6669. Epub 2024 Mar 6. Sci Adv. 2024. PMID: 38446886 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources

